‘Significant step’ as health authority approves J&J Covid-19 vaccine — with conditions

‘Significant step’ as health authority approves J&J Covid-19 vaccine — with conditions

SA has recorded another positive development in the fight against Covid-19, as the SA Health Products Regulatory Authority (Sahpra) approved the Johns

Covid-19: India reports 53,480 new cases, 354 deaths in 24 hours
Why the world would end without health care providers
Spring Vegetable Minari Goes Well with Almost Any Kind of Food

SA has recorded another positive development in the fight against Covid-19, as the SA Health Products Regulatory Authority (Sahpra) approved the Johnson & Johnson vaccine — albeit with some conditions.

In a statement, Sahpra said it had registered the single-dose vaccine, which is developed by the J&J vaccine arm Janssen Pharmaceutical Companies, on March 31. One of the conditions include that the vaccine should be supplied and administered under the national department of health’s Covid-19 vaccination plan and applicable guidelines.

The regulatory body said the Covid-19 vaccine was an adenovirus type 26 vectored vaccine indicated for active immunisation against SARS-CoV-2. The administration of the Janssen Covid-19 Vaccine may contribute to protection against Covid-19.

“This registration signals a significant step in the fight against the Covid-19 pandemic. This authorisation is based on acceptable safety, quality and efficacy data submitted by Janssen Pharmaceutica to Sahpra as a rolling submission over the period December 11 2020 to March 17 2021,” said the regulatory authority.

Read More

COMMENTS

WORDPRESS: 0
DISQUS: 0